Sign in

CIK 0001228627

  • Non-accelerated filer
  • Smaller reporting company

Opus Genetics, Inc.

Sign in to watch
Ticker
IRD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
113516358
Phone
+1 984-884-6030
Business address
8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
Former names
Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,211,769
in 7 filings, $50K under 10b5-1 plans

Net −$3,211,769. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 46 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-02-28 Suzdak Peter David Chief Executive Officer Exercise or conversion +6,250 22,250
2018-02-28 Suzdak Peter David Chief Executive Officer Exercise or conversion · Restricted Stock Units +6,250 18,750
2018-01-26 Suzdak Peter David Chief Executive Officer Grant or award · Stock Option (right to buy) +112,271 112,271
2017-08-16 Suzdak Peter David Chief Executive Officer Grant or award +10,000 $1.99 $20K 16,000
2017-01-20 Suzdak Peter David Chief Executive Officer Grant or award · Stock Option (right to buy) +1,175,000 1,175,000
2017-01-20 Suzdak Peter David Chief Executive Officer Grant or award · Restricted Stock Units +250,000 250,000
2016-03-18 Suzdak Peter David Chief Executive Officer Grant or award +60,000 $0.32 $19K 60,000
2016-01-28 Suzdak Peter David Chief Executive Officer Grant or award · Stock Option (right to buy) +411,689 411,689
2016-01-28 Suzdak Peter David Chief Executive Officer Grant or award · Stock Option (right to buy) +1,000,000 1,000,000
2015-01-23 Suzdak Peter David Chief Executive Officer Grant or award · Stock Option (right to purchase) +1,100,000 1,100,000
2014-09-04 Suzdak Peter David Chief Executive Officer Grant or award · Stock Option (right to purchase) +1,000,000 1,000,000
2014-01-12 Suzdak Peter David Chief Executive Officer Grant or award · Stock Option (right to purchase) +350,000 350,000
2013-02-04 Suzdak Peter David Chief Executive Officer Grant or award · Stock Option (right to purchase) +1,200,000 1,200,000

Page 1 of 1 · 13 trades